CCIA
KYNB

Campbell & Co Investment Adviser’s Kyntra Bio KYNB Stock Holding History

Campbell & Co Investment Adviser’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-408
Closed -$104K – 667
2021
Q3 		$104K Buy
+408
New +$145K 0.03% 560

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Campbell & Co Investment Adviser's KYNB Position: Q4 2021 in Review

Campbell & Co Investment Adviser sold out of Kyntra Bio (KYNB) in Q4 2021, closing a stake of 408 shares — an estimated $104K sold.

Campbell & Co Investment Adviser first reported a position in KYNB in Q3 2021 and held it in 1 quarter. The position peaked at $104K in Q3 2021. 162 funds tracked by Wall St. Rank hold KYNB as of Q4 2021.

  • Campbell & Co Investment Adviser reported no remaining Kyntra Bio position as of Q4 2021 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 408 Kyntra Bio shares in Q4 2021, an estimated $104K.
  • Campbell & Co Investment Adviser first reported a position in Kyntra Bio in Q3 2021 and held it in 1 quarter.
  • Campbell & Co Investment Adviser's Kyntra Bio position peaked at $104K in Q3 2021.
  • 162 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2021.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2021, filed 10 Feb 2022.